SPRY   $14.82  -0.27% Market Open

ARS Pharmaceuticals Inc
Total Cash 218.74M
totalCashPerShare 2.256
EBITDA -56.67M
Total Debt 160.00K
quickRatio 32.608
currentRatio 32.823
Total Revenue 500.00K
debtToEquity 0.074
Revenue/Share 0.005
ROA -0.14753
ROE -0.19337
grossProfits
freeCashflow -26.33M
operatingCashflow -44.16M
earningsGrowth
revenueGrowth 49.0
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -30.68
profitMargins 0.0
enterpriseValue 1.07B
forwardPE -14.715909
floatShares 44.65M
sharesOutstanding 96.94M
sharesShort 10.96M
sharesShortPriorMonth 9.93M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.23%
heldPercentInstitutions 0.64%
Short Ratio help_outline 7.39%
shortPercentOfFloat 0.21%
impliedSharesOutstanding
bookValue 2.22
Price To Book help_outline 5.83
earningsQuarterlyGrowth
netIncomeToCommon -44.84M
trailingEps -0.47%
forwardEps -0.88%
enterpriseToEbitda -18.89
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.15 3Q 2024
institutionsCount 166
lastUpdated Sept. 17, 2024, 2:17 a.m.